ATE290533T1 - 2,2-disubstituierte 1,3-dioxolane als hustenmittel - Google Patents

2,2-disubstituierte 1,3-dioxolane als hustenmittel

Info

Publication number: ATE290533T1
Authority: AT; Austria
Prior art keywords: dioxolans; disubstituted; cough remedies; remedies; cough
Prior art date: 2000-07-28

Application number

AT01960513T

Other languages

English (en)

Inventor

Marcello Allegretti

Maria Candida Cesta

Roberto Curti

Luca Nicolini

Original Assignee

Dompe Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-28

Filing date

2001-07-18

Publication date

2005-03-15

2001-07-18 Application filed by Dompe Spa filed Critical Dompe Spa

2005-03-15 Application granted granted Critical

2005-03-15 Publication of ATE290533T1 publication Critical patent/ATE290533T1/de

Links

-1 (±) 3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals Chemical class 0.000 abstract 1
PTVWPYVOOKLBCG-UHFFFAOYSA-N 3-(4-phenyl-1-piperazinyl)propane-1,2-diol Chemical compound C1CN(CC(O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-UHFFFAOYSA-N 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
PTVWPYVOOKLBCG-ZDUSSCGKSA-N levodropropizine Chemical compound C1CN(C[C@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-ZDUSSCGKSA-N 0.000 abstract 1
229960002265 levodropropizine Drugs 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Holo Graphy (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Hydrogenated Pyridines (AREA)
Glass Compositions (AREA)
Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Fats And Perfumes (AREA)
Liquid Crystal Substances (AREA)
Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Secondary Cells (AREA)

AT01960513T 2000-07-28 2001-07-18 2,2-disubstituierte 1,3-dioxolane als hustenmittel ATE290533T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2000MI001735A IT1318651B1 (it)	2000-07-28	2000-07-28	Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
PCT/EP2001/008305 WO2002010150A1 (en)	2000-07-28	2001-07-18	2,2-disubstituted 1,3-dioxolanes as antitussive agents

Publications (1)

Publication Number	Publication Date
ATE290533T1 true ATE290533T1 (de)	2005-03-15

Family

ID=11445592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01960513T ATE290533T1 (de)	2000-07-28	2001-07-18	2,2-disubstituierte 1,3-dioxolane als hustenmittel

Country Status (24)

Country	Link
US (1)	US6916926B2 (de)
EP (1)	EP1307440B1 (de)
JP (1)	JP5015403B2 (de)
KR (1)	KR100788532B1 (de)
CN (1)	CN1216053C (de)
AT (1)	ATE290533T1 (de)
AU (1)	AU2001281992A1 (de)
BR (1)	BR0112802A (de)
CZ (1)	CZ301039B6 (de)
DE (1)	DE60109299T2 (de)
EE (1)	EE05159B1 (de)
ES (1)	ES2237589T3 (de)
HU (1)	HU229801B1 (de)
IL (2)	IL153502A0 (de)
IT (1)	IT1318651B1 (de)
MX (1)	MXPA02012922A (de)
PL (1)	PL206308B1 (de)
PT (1)	PT1307440E (de)
RS (1)	RS50862B (de)
RU (1)	RU2269522C2 (de)
SI (1)	SI21041B (de)
SK (1)	SK286795B6 (de)
UA (1)	UA73790C2 (de)
WO (1)	WO2002010150A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1318650B1 (it) *	2000-07-28	2003-08-27	Dompe Spa	1,3-diossolani ad attivita' antitosse.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4049660A (en) *	1971-06-18	1977-09-20	Delalande S.A.	N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1210639B (it) *	1981-02-25	1989-09-14	Menarini Sas	Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione
IT1203721B (it)	1983-12-29	1989-02-23	Dompe Farmaceutici Spa	Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
SE449516B (sv) *	1984-10-16	1987-05-04	Skf Nova Ab	Klemring med reglerbar halomkrets
IT1254452B (it) *	1992-02-14	1995-09-25	Dompe Farmaceutici Spa	N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IL111730A (en) *	1993-11-29	1998-12-06	Fujisawa Pharmaceutical Co	Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
DE69722360T2 (de) *	1996-06-29	2003-11-27	Samjin Pharm, Co.	Piperazin-derivate und verfahren zu ihrer herstellung
IT1318650B1 (it) *	2000-07-28	2003-08-27	Dompe Spa	1,3-diossolani ad attivita' antitosse.

2000
- 2000-07-28 IT IT2000MI001735A patent/IT1318651B1/it active
2001
- 2001-07-18 BR BR0112802-7A patent/BR0112802A/pt not_active Application Discontinuation
- 2001-07-18 UA UA2003021768A patent/UA73790C2/uk unknown
- 2001-07-18 KR KR1020037000943A patent/KR100788532B1/ko not_active Expired - Fee Related
- 2001-07-18 US US10/312,290 patent/US6916926B2/en not_active Expired - Fee Related
- 2001-07-18 RS YUP-31/03A patent/RS50862B/sr unknown
- 2001-07-18 ES ES01960513T patent/ES2237589T3/es not_active Expired - Lifetime
- 2001-07-18 PT PT01960513T patent/PT1307440E/pt unknown
- 2001-07-18 AU AU2001281992A patent/AU2001281992A1/en not_active Abandoned
- 2001-07-18 SI SI200120037A patent/SI21041B/sl not_active IP Right Cessation
- 2001-07-18 HU HU0301473A patent/HU229801B1/hu not_active IP Right Cessation
- 2001-07-18 SK SK90-2003A patent/SK286795B6/sk not_active IP Right Cessation
- 2001-07-18 EE EEP200300035A patent/EE05159B1/xx not_active IP Right Cessation
- 2001-07-18 PL PL361173A patent/PL206308B1/pl unknown
- 2001-07-18 CN CN018134572A patent/CN1216053C/zh not_active Expired - Fee Related
- 2001-07-18 CZ CZ20030269A patent/CZ301039B6/cs not_active IP Right Cessation
- 2001-07-18 MX MXPA02012922A patent/MXPA02012922A/es active IP Right Grant
- 2001-07-18 AT AT01960513T patent/ATE290533T1/de active
- 2001-07-18 EP EP01960513A patent/EP1307440B1/de not_active Expired - Lifetime
- 2001-07-18 JP JP2002515881A patent/JP5015403B2/ja not_active Expired - Fee Related
- 2001-07-18 RU RU2003105692/04A patent/RU2269522C2/ru not_active IP Right Cessation
- 2001-07-18 DE DE60109299T patent/DE60109299T2/de not_active Expired - Lifetime
- 2001-07-18 WO PCT/EP2001/008305 patent/WO2002010150A1/en not_active Ceased
- 2001-07-18 IL IL15350201A patent/IL153502A0/xx active IP Right Grant
2002
- 2002-12-17 IL IL153502A patent/IL153502A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ301039B6 (cs)	2009-10-21
CN1216053C (zh)	2005-08-24
SK902003A3 (en)	2003-09-11
RU2269522C2 (ru)	2006-02-10
JP2004505074A (ja)	2004-02-19
SK286795B6 (sk)	2009-05-07
ITMI20001735A1 (it)	2002-01-28
KR20030016424A (ko)	2003-02-26
KR100788532B1 (ko)	2007-12-24
UA73790C2 (uk)	2005-09-15
US6916926B2 (en)	2005-07-12
EP1307440A1 (de)	2003-05-07
CZ2003269A3 (cs)	2003-06-18
WO2002010150A1 (en)	2002-02-07
ITMI20001735A0 (it)	2000-07-28
PT1307440E (pt)	2005-05-31
PL206308B1 (pl)	2010-07-30
JP5015403B2 (ja)	2012-08-29
BR0112802A (pt)	2003-07-01
HUP0301473A2 (hu)	2003-08-28
EE05159B1 (et)	2009-04-15
DE60109299T2 (de)	2005-07-21
ES2237589T3 (es)	2005-08-01
RS50862B (sr)	2010-08-31
IL153502A0 (en)	2003-07-06
SI21041A (sl)	2003-04-30
EP1307440B1 (de)	2005-03-09
IL153502A (en)	2006-12-10
SI21041B (en)	2005-08-31
MXPA02012922A (es)	2003-10-06
IT1318651B1 (it)	2003-08-27
YU3103A (sh)	2006-05-25
AU2001281992A1 (en)	2002-02-13
DE60109299D1 (de)	2005-04-14
EE200300035A (et)	2004-10-15
HU229801B1 (en)	2014-07-28
CN1444579A (zh)	2003-09-24
HK1058798A1 (en)	2004-06-04
PL361173A1 (en)	2004-09-20
US20030176446A1 (en)	2003-09-18

Legal Events

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1307440

Country of ref document: EP

2007-08-15

EEIH

Change in the person of patent owner

Publication	Publication Date	Title
ATE181551T1 (de)	1999-07-15	Taxol-derivate
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
DK0863875T3 (da)	2003-12-01	Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser
ATE274353T1 (de)	2004-09-15	Verwendung von aufgereinigtem invaplex als impfstoff für gram-negativebakterien
ATE211732T1 (de)	2002-01-15	N-benzylpiperidin- und tetrahydropyridin-derivate
EP1589018A4 (de)	2007-03-14	Herstellungsverfahren für hexahydrofurofuranol-derivate, zwischenprodukt davon und herstellungsverfahren dafür
DE69940833D1 (de)	2009-06-10	Verfahren zur Herstellung von Arylethern
EA200400806A1 (ru)	2004-12-30	Способ получения эхинокандиновых соединений
BR0114380A (pt)	2003-12-30	Derivados-1-aminobutan-3-ol-substituìdos
ATE290533T1 (de)	2005-03-15	2,2-disubstituierte 1,3-dioxolane als hustenmittel
TR200402546T4 (tr)	2004-12-21	Taksan türevleri hazırlamak için işlem.
BR0110996A (pt)	2003-03-18	Método para preparação de citalopram; composto; intermediário e, sua composição farmacêutica
DK1307441T3 (da)	2004-08-09	1,3-dioxolaner med en hostehæmmende virkning
EA200201210A1 (ru)	2003-04-24	Синтетический способ получения соединения эктеинасцидина
HUP9903765A2 (hu)	2000-03-28	Eljárás 3-(1-piperazinil)-1,2-benzizotiazol előállítására, valamint ennek közbenső termékei
EA200200741A1 (ru)	2002-12-26	Способ получения эфиров арилиминометилкарбаминовой кислоты
DE69009698D1 (de)	1994-07-14	Verfahren zur Herstellung von Halogenacetalen aus Enaminen.
DE3683352D1 (de)	1992-02-20	Verfahren zur herstellung von indolinen.
UY26638A1 (es)	2001-10-25	Nuevos derivados de piperazina